Lantern Pharma Statistics
Share Statistics
Lantern Pharma has 10.78M
shares outstanding. The number of shares has increased by 0.24%
in one year.
| Shares Outstanding | 10.78M |
| Shares Change (YoY) | 0.24% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 23.23% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 2,959 |
| FTD / Avg. Volume | 6.59% |
Short Selling Information
The latest short interest is 273.11K, so 2.53% of the outstanding
shares have been sold short.
| Short Interest | 273.11K |
| Short % of Shares Out | 2.53% |
| Short % of Float | 2.88% |
| Short Ratio (days to cover) | 4.81 |
Valuation Ratios
| PE Ratio | 0 |
| Forward PE | -3.18 |
| PS Ratio | 0 |
| Forward PS | 1.1 |
| PB Ratio | 0 |
| P/FCF Ratio | -1.93 |
| PEG Ratio | 0 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Lantern Pharma.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.01,
with a Debt / Equity ratio of 0.
| Current Ratio | 0.01 |
| Quick Ratio | 0.01 |
| Debt / Equity | 0 |
| Debt / EBITDA | -0.01 |
| Debt / FCF | -0.01 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | $-865,883,875 |
| Employee Count | 24 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -41.79% in the
last 52 weeks. The beta is 1.62, so Lantern Pharma's
price volatility has been higher than the market average.
| Beta | 1.62 |
| 52-Week Price Change | -41.79% |
| 50-Day Moving Average | 3.59 |
| 200-Day Moving Average | 3.8 |
| Relative Strength Index (RSI) | 51.2 |
| Average Volume (20 Days) | 44,927 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -22.22B |
| Net Income | -20.78B |
| EBITDA | -20.59M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -1930.92 |
Full Income StatementBalance Sheet
The company has 7.51M in cash and 243.66K in
debt, giving a net cash position of 7.27M.
| Cash & Cash Equivalents | 7.51M |
| Total Debt | 243.66K |
| Net Cash | 7.27M |
| Retained Earnings | -76.03B |
| Total Assets | 25.57M |
| Working Capital | 20.92M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -17.81M
and capital expenditures 0, giving a free cash flow of -17.83M.
| Operating Cash Flow | -17.81M |
| Capital Expenditures | n/a |
| Free Cash Flow | -17.83M |
| FCF Per Share | -1.66 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
